Octagon Capital Advisors LP
Top Portfolio Positions
29 positions ·
$906,562,532 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
1,946,667 | $163,364,294 | 18.02% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
2,350,000 | $90,451,500 | 9.98% | |
| ABVX |
Abivax S.A.
Healthcare
|
677,000 | $75,383,950 | 8.32% | |
| ALMS |
Alumis Inc.
Healthcare
|
2,830,700 | $62,360,321 | 6.88% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
2,440,000 | $46,116,000 | 5.09% | |
| AVBP |
ArriVent BioPharma, Inc.
Healthcare
|
1,971,054 | $45,472,215 | 5.02% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
8,859,911 | $39,603,802 | 4.37% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
425,000 | $35,398,250 | 3.90% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
338,900 | $31,307,582 | 3.45% | |
| BIOA |
BioAge Labs, Inc.
Healthcare
|
1,748,000 | $30,572,520 | 3.37% |
Portfolio Trend
22 quarters · across all stocks
Holdings in GOSS
Shares Held
Position Value (USD)
24 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,953,121 | 8,976,054 | Shares | Sole | 2026-05-14 | |
| 2026-03-31 | $2,549,750 | 7,750,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $43,137,650 | 13,915,371 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $44,841,500 | 17,050,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $22,570,500 | 18,350,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $20,185,000 | 18,350,000 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $16,606,750 | 18,350,000 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $17,716,328 | 19,576,054 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $9,059,252 | 9,187,883 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,278,282 | 9,187,883 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,841,701 | 9,187,883 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $8,388,537 | 9,187,883 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,820,506 | 8,187,883 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,749,682 | 3,958,069 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,467,166 | 1,958,069 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,249,009 | 1,958,069 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $24,504,395 | 2,045,442 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $23,085,037 | 2,758,069 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $22,248,037 | 2,563,138 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $17,113,590 | 1,513,138 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $19,020,144 | 1,513,138 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $11,474,680 | 1,413,138 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $13,071,526 | 1,413,138 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $15,115,544 | 1,563,138 | Shares | Sole | 2021-02-16 | |
| No 13F history on record for this holder in this stock. | ||||||